Biography of Michael Metzger
Last update: November 25, 2023Career
Michael was President and Chief Operating Officer at Syndax Pharmaceuticals, and Executive Vice President and Chief Operating Officer at Mersana Therapeutics.
Michael Metzger is currently Director at CTI BioPharma - View - CTI BioPharma org chart
Create your alert
to follow the career of Michael Metzger.
Education
Michael Metzger has a Bachelor of Arts from George Washington University and a Master of Business Administration in Finance from New York University - Leonard N. Stern School of Business.
They have also studied at George Washington University :
- William Opet - JPMorgan Chase
- Michelle Ingrassia - Amtrust Financial Services
- Courtney Huggins - JLL
Find more alumni from George Washington University
They have also studied at New York University - Leonard N. Stern School of Business :
Find more alumni from New York University - Leonard N. Stern School of Business
More about Michael Metzger
Selected links
Do you need to know more about Michael Metzger? More results.
Participate
Social media
- Michael Metzger on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Michael Metzger
The colleagues of Michael Metzger
Company Colleagues
- At CTI BioPharma, Michael Metzger has 20 colleagues including Matthew Perry (Director), Laurent Fischer (Chairman of the Board)…
Homonyms
- Michael Metzger - Global Chief Information Officer - Sazerac
- Michael Metzger - Director and Chief Executive Officer - Syndax Pharmaceuticals
Industry Colleagues
- In the Biotechnology industry, Michael Metzger has 30,259 colleagues in 2,283 companies located in 40 countries. 14,408 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Michael Metzger.
Get in Touch
Sorry, but Michael Metzger cannot be contacted yet through our email service. Please use our Premium/VIP service to join colleagues of Michael Metzger listed below. Here are a few tips for establishing great contacts.
